Double Bond Pharmaceutical Competitors and Similar CompaniesClear all
Double Bond Pharmaceutical's competitors and similar companies include Turning Point Therapeutics, NATCO Pharma and Pharmstandard.
 Double Bond Pharmaceutical Double Bond Pharmaceutical is a company that develops approaches for treatment of cancers. |  Turning Point Therapeutics Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases. |  NATCO Pharma NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API). |  Pharmstandard Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products. | |
Founding Date | Founding Date 2014 | Founding Date 2013 | Founding Date 1981 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations Uppsala, SE HQ Uppsala, SE | Locations San Diego, US HQ | Locations Hyderabad, IN HQ Central Hope Town, IN Chennai, IN Hyderabad, IN Santola, IN Vijayapuri North, IN | Locations Dolgoprudny, RU HQ Kursk, RU Moscow, RU Petrovo Dalnee, RU Tomsk, RU Ufa, RU Vol'ginskii, RU |
Employees | Employees 1318% increase | Employees 474% decrease | Employees 4,016 | Employees 1,77814% increase |
Financial | ||||
Revenue (est.) | Revenue (est.) kr84k (FY, 2025) | Revenue (est.) $30.8m (FY, 2021) | Revenue (est.) ₹40.8b (FY, 2026) | Revenue (est.) ₽152.1b (FY, 2024) |
Cost of goods | Cost of goods kr125k (FY, 2025) | Cost of goods N/A | Cost of goods ₹6.9b (FY, 2026) | Cost of goods ₽117b (FY, 2024) |
Gross profit | Gross profit (kr25k) (FY, 2025) | Gross profit N/A | Gross profit ₹36.9b (FY, 2026) | Gross profit ₽35.2b (FY, 2024) |
Net income | Net income (kr333k) (FY, 2025) | Net income ($236.6m) (FY, 2021) | Net income ₹13.7b (FY, 2026) | Net income ₽22.7b (FY, 2024) |
Funding | ||||
Total funding raised | Total funding raised $ 81.7k | Total funding raised $ 144.4m | Total funding raised N/A | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Turning Point Therapeutics
HQ
San Diego, US
Turning Point Therapeutics (TP Therapeutics) is a precision oncology company that is engaged in medicine discovery for cancer and other diseases.
View companyNATCO Pharma
HQ
Hyderabad, IN
Employees
4,016
NATCO Pharma is a company focused on research, manufacturing, and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (API).
View companyPharmstandard
HQ
Dolgoprudny, RU
Pharmstandard (also known as АО Фармстандарт) is a company that develops and manufactures pharmaceutical products.
View company